committee conditionally favored continuous use of NSAIDs in patients with active AS, primarily for controlling disease activity. The decision to use NSAIDs continuously may vary depending on the severity of symptoms, patient preferences, and comorbidities, particularly gastrointestinal and kidney comorbidities, and cardiovascular disease. In adults with active AS despite treatment with NSAIDs, we conditionally recommend treatment with sulfasalazine, methotrexate, or tofacitinib over no